Charles E. Davis

10.7k total citations · 3 hit papers
132 papers, 8.2k citations indexed

About

Charles E. Davis is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Charles E. Davis has authored 132 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 39 papers in Infectious Diseases and 25 papers in Molecular Biology. Recurrent topics in Charles E. Davis's work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (16 papers) and Trypanosoma species research and implications (15 papers). Charles E. Davis is often cited by papers focused on HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (16 papers) and Trypanosoma species research and implications (15 papers). Charles E. Davis collaborates with scholars based in United States, Nigeria and Canada. Charles E. Davis's co-authors include Omar M. Yaghi, Hailian Li, Thomas L. Groy, David J. Richardson, Abraham I. Braude, Guangming Li, Herndon Douglas, Wayne M. Dankner, Karen Arnold and Robert Redfield and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Charles E. Davis

124 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthetic Strategies, Structure Patterns, and Emerging Properties in the Chemistry of Modular Porous Solids

1998 2.0k citations Omar M. Yaghi, Charles E. Davis et al. profile →
Selective Guest Binding by Tailored Channels in a 3-D Porous Zinc(II)−Benzenetricarboxylate Network

1997 671 citations Omar M. Yaghi, Charles E. Davis et al. profile →
Coordinatively Unsaturated Metal Centers in the Extended Porous Framework of Zn₃(BDC)₃·6CH₃OH (BDC = 1,4-Benzenedicarboxylate)

1998 345 citations Charles E. Davis, Thomas L. Groy et al. profile →

Peers

Countries citing papers authored by Charles E. Davis

Since Specialization

Citations

This map shows the geographic impact of Charles E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Davis more than expected).

Fields of papers citing papers by Charles E. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Davis. The network helps show where Charles E. Davis may publish in the future.

Co-authorship network of co-authors of Charles E. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Davis. A scholar is included among the top collaborators of Charles E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Davis. Charles E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association Between Duration of Human Immunodeficiency Virus (HIV)–1 Viral Suppression Prior to Renal Transplantation and Acute Cellular Rejection 2016 ·American Journal of Transplantation ·Jennifer Husson, Kristen A. Stafford, Jonathan S. Bromberg, Abdolreza Haririan, (unknown), Charles E. Davis, Robert Redfield, Antonio Amoroso	11
2	Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice 2015 ·Proceedings of the National Academy of Sciences ·Alonso Heredia, Nhut Le, Ronald B. Gartenhaus, Edward A. Sausville, Sandra Medina-Moreno, Juan Carlos Zapata, Charles E. Davis, Robert C. Gallo, Robert Redfield	79
3	Targeting of the Purine Biosynthesis Host Cell Pathway Enhances the Activity of Tenofovir Against Sensitive and Drug-Resistant HIV-1 2013 ·The Journal of Infectious Diseases ·Alonso Heredia, Charles E. Davis, M S Reitz, Nhut Le, Mark A. Wainberg, James S. Foulke, Lai‐Xi Wang, Robert Redfield	14
4	Tenofovir and Abacavir Combination Therapy: Lessons Learned from an Urban Clinic Population 2007 ·AIDS Patient Care and STDs ·Bruce L. Gilliam, Mohammad M. Sajadi, Anthony Amoroso, Charles E. Davis, Farley Cleghorn, Robert Redfield	9
5	Brucellosis in San Diego 2005 ·Medicine ·Stephanie B. Troy, Leland S. Rickman, Charles E. Davis	46
6	The effect of moving to a new hospital facility on the prevalence of methicillin-resistant Staphylococcus aureus 2004 ·American Journal of Infection Control ·Nicholas J. Vietri, David P. Dooley, Charles E. Davis, Jenice N. Longfield, Patricia A. Meier, A. Christian Whelen	27
7	Resveratrol glucuronides as the metabolites of resveratrol in humans: Characterization, synthesis, and anti-HIV activity 2004 ·Journal of Pharmaceutical Sciences ·Lai‐Xi Wang, Alonso Heredia, Haijing Song, Zhaojun Zhang, Biao Yu, Charles E. Davis, Robert Redfield	106
8	Synergistic Inhibition of HIV-1 in Activated and Resting Peripheral Blood Mononuclear Cells, Monocyte-Derived Macrophages, and Selected Drug-Resistant Isolates With Nucleoside Analogues Combined With a Natural Product, Resveratrol 2000 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Alonso Heredia, Charles E. Davis, Robert Redfield	67
9	Purification, Cloning, and Characterization of an Acidic Ectoprotein Phosphatase Differentially Expressed in the Infectious Bloodstream Form of Trypanosoma brucei 2000 ·Journal of Biological Chemistry ·Norbert Bakalara, Xavier Santarelli, Charles E. Davis, Théo Baltz	53
10	Nosocomial Transmission of Mycobacterium bovis Bacille Calmette-Guerin to Children Receiving Cancer Therapy and to Their Health Care Providers 2000 ·Clinical Infectious Diseases ·Norman J. Waecker, Rossina Stefanova, M. Donald Cave, Charles E. Davis, Wayne M. Dankner	19
11	Repeated Immunization with Recombinant gp160 Human Immunodeficiency Virus (HIV) Envelope Protein in Early HIV‐1 Infection: Evaluation of the T Cell Proliferative Response 1999 ·The Journal of Infectious Diseases ·Silvia Ratto‐Kim, Karl Sitz, Robin P. Garner, Jérôme H. Kim, Charles E. Davis, Naomi Aronson, Nancy Ruíz, (unknown), Robert Redfield, Deborah L. Birx	22
12	ChemInform Abstract: Synthetic Strategies, Structure Patterns, and Emerging Properties in the Chemistry of Modular Porous Solids 1998 ·ChemInform ·Omar M. Yaghi, (unknown), Charles E. Davis, David J. Richardson, Thomas L. Groy	2
13	An immunoassay for the detection and quantitative determination of mycothiol 1998 ·Journal of Immunological Methods ·M. D. Unson, Gerald L. Newton, Charles E. Davis, Robert C. Fahey	24
14	Predictors of HIV-1 Disease Progression in Early- and Late-Stage Patients 1992 ·Lytt I. Gardner, John F. Brundage, John G. McNeil, Mark Milazzo, Robert R. Redfield, Naomi Aronson, (unknown), Charles E. Davis, (unknown), Lynn I. Levin, (unknown), Charles N. Oster, (unknown), Donald S. Burke, Edmund C. Tramont	7
15	Cloning and sequencing of the cysteine protease cDNA fromTrypanosoma brucei rhodesiense 1990 ·Nucleic Acids Research ·Eric G. Pamer, Charles E. Davis, (unknown), Magdalene So	22
16	myc-related proteins and DNA sequences in Trypanosoma brucei 1989 ·Microbial Pathogenesis ·Charles E. Davis, (unknown), (unknown), (unknown), Donald G. Guiney	9
17	Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. 1988 ·The Journal of Immunology ·Miodrag Belosevic, Charles E. Davis, Monte S. Meltzer, Carol A. Nacy	131
18	In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. 1986 ·Journal of Clinical Investigation ·Andreas Schaffner, Charles E. Davis, T Schaffner, M. Markert, Herndon Douglas, Abraham I. Braude	117
19	The Fetid Foot: Lower-Extremity Infections In Patients with Diabetes Mellitus 1979 ·Clinical Infectious Diseases ·Joshua Fierer, (unknown), Charles E. Davis	53
20	Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. 1976 ·The Journal of Experimental Medicine ·Carol J. Baker, Dennis L. Kasper, Charles E. Davis	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact